Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years

NCT01096368 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01096368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01096368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
May 7, 2010
Completion date
March 31, 2026
Enrollment
479 (actual)
Sites
209

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic ependymoma, brain ependymoma, cellular ependymoma, clear cell ependymoma, ependymoma, papillary ependymoma